Preferred Label : metastatic to;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.louvainmedical.be/fr/article/comment-aborder-la-premiere-ligne-therapeutique-dans-le-carcinome-renal-cellules-claires
2024
Belgium
journal article
combined
clear cell renal cell carcinoma
clear cell adenocarcinoma, nos
kidney, nos
metastatic to
activir
immunotherapy
immunotherapy, nos
carcinoma, renal cell
base, nos
therapeutics
watchful waiting

---
https://pgtmsite.files.wordpress.com/2024/01/ad-pembro_rapport-final1.pdf
2022
Canada
drug information
neoplasm, malignant
quebec
pembrolizumab
carcinoma, non-small-cell lung
Nonmetastatic
CYRIB wt Allele
L1 Stage Finding
Metastatic
Daur Chinese
lupus erythematosus cell
Lower Esophageal Sphincter
Lung Non-Small Cell Carcinoma
metastatic to
L1 Mouse
small cell lung carcinoma
patients
Patient
has patient
LE cells
Due
Long Interspersed Nucleotide Element-1
Pembrolizumab
Identifier
Intent To Treat
Device-In-Use Domain
Metastatic Malignant Neoplasm
Deoxyuridine
B7-H1 Antigen
pembrolizumab
pembrolizumab
intention to treat analysis
Analysis
hospitals, university
neutrophils
Cancer Therapeutic Procedure
Analyzed
Description
INRG Stage L1

---
Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.